Dec 18, 2023 | Past Events
The Italian Midcap Conference provides an opportunity for investors to get a perspective of Philogen progresses and to meet CEO Dario Neri and CFO Laura Baldi through a series of one-on-one meetings.Dec 18, 2023 | Past Events
Prof. Dr. Giuseppe Curigliano, on behalf of Philogen, is giving a presentation about the Phase I DODEKA study on February 26th, entitled “Phase I dose-escalation trial with tumor-targeted interleukin-12 (IL12-L19L19) in patients with solid tumors”. Dr. Jacqueline Mock...Dec 4, 2023 | 2023, Investors, Past Events
Please contact us at ir@philogen.com or follow the link below to register to the event: https://us06web.zoom.us/webinar/register/1616473304091/WN_UQLuGhWHTtuozv1NvDMvMQ#/registrationOct 27, 2023 | Past Events
Prof. Dario Neri, PhD, (CEO and CSO of Philogen) is giving a presentation entitled “From encoded combinatorial libraries to clinical-stage targeted therapeutics”. Follow the link here for more detailsOct 16, 2023 | 2023, Investors, Past Events
The Webinar will be hosted by Prof. Dr. Dario Neri (CEO and CSO), Dr. Laura Baldi (CFO), Dr. Emanuele Puca (Investor Relations). Please follow the link below to register to the Webinar:...Sep 29, 2023 | Past Events
We are delighted to invite you to our virtual briefing on 2 October 2023 to discuss the Company’s Half Year 2023 Results.Prof. Dr. Dario Neri, Chief Executive Officer, Dr. Laura Baldi, Chief Financial Officer, and Dr. Emanuele Puca, Head of Investor Relations, will...
Recent Comments